Companies › ICCC
IMMUCELL CORP (ICCC)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0000811641 · EDGAR filings · Updated 2026-07-09
IMMUCELL CORP (ICCC) has reported institutional ownership of 15.1%, with 27 institutional managers holding positions valued at $8.67M per the latest 13F reporting period. SEC filings include an active material impairment disclosure (8-K Item 2.06), non-reliance notice on previously issued financial statements (8-K Item 4.02).
Latest updates
- 2026-07-09 — Current report (8-K) filed
- 2026-06-22 — Insider transaction reported (Form 4)
- 2026-06-17 — Current report (8-K) filed
- 2026-06-10 — Current report (8-K) filed
- 2026-05-14 — Current report (8-K) filed
- 2026-05-14 — Quarterly report (10-Q) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, IMMUCELL CORP has 27 institutional holders and institutional ownership of 15.1%.
Insider activity
Insiders reported 11 transactions (8 buys, 0 sells) across 5 reporting insiders, with a net reported value of $102.0K.
Data flags from SEC filings
Related companies
ONEMEDNET CORP (ONMD) · CITIUS ONCOLOGY INC COM (CTOR) · Entera Bio Ltd (ENTX) · METAGENOMI THERAPEUTICS INC (MGX) · MYOMO INC (MYO) · Curis Inc (CRIS)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-09.